NBK PHARMACEUTICS LTD
Significant control: Naeem Bilal Kazee (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Nbk Pharmaceutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Nbk Pharmaceutics Ltd sell?
Registered activity: Dispensing chemist in specialised stores (SIC 47730). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
NBK PHARMACEUTICS LTD is an active private limited company (company number 13967007) incorporated on 10 March 2022, registered in Cheadle. Its registered activity is dispensing chemist in specialised stores (SIC 47730). Latest micro accounts cover the period ending 31 March 2026, showing net assets of £21k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 34% on the prior period (£31k).
By net assets it sits in the upper half of 569 comparable companies in Manchester (median £5,809, upper quartile £88k).
Ownership and control
- Mr Naeem Bilal Kazee
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 10 March 20224 yrs ago
- Next accounts due
- 31 December 2027in 433 days
- Confirmation statement due
- 24 March 2027in 151 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 47730
- Dispensing chemist in specialised stores
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | £21k | — | — | £16k | — | — | 2 |
| 31 March 2025 | £31k | — | — | £16k | — | — | 1 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £20,613 at 31 March 2026
- Net assets down 25% or more on the prior period-34.2% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.32
- Incorporated two to five years agoIncorporated 10 March 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 433 days
- Confirmation statement duein 151 days
- Accounts period endNet assets £21k · micro accounts
- Accounts period endNet assets £31k · micro accounts
- Incorporated
Similar companies in Manchester
- ARISHAN LTDCheadle · inc. Mar 2022
- LOCUM DIRECTION LTDManchester · inc. Mar 2022
- BAMED LTDBolton · inc. Feb 2022
- YAYOI CARE LTDManchester · inc. Feb 2022
- TEE JAY HEALTHCARES LIMITEDRochdale · inc. Feb 2022
- META-PHAR CARE LTDManchester · inc. Feb 2022
All companies incorporated on 10 March 2022 · in Mar 2022.
Reminders for NBK PHARMACEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.